4.5 Review

Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases

期刊

MEDIATORS OF INFLAMMATION
卷 2012, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2012/125458

关键词

-

资金

  1. FPU programme of Spanish Ministry of Education
  2. Instituto de Salud Carlos III
  3. Xunta de Galicia (SERGAS) through a research staff stabilization contract
  4. Xunta de Galicia
  5. RETICS Program
  6. RIER [RD08/0075]
  7. REDINSCOR from Instituto de Salud Carlos III (ISCIII), within the VI NP of R + D + I
  8. [PI11/01073]
  9. [PI11/00497]

向作者/读者索取更多资源

Patients with rheumatic diseases have an increased risk of mortality by cardiovascular events. In fact, several rheumatic diseases such as rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, and ankylosing spondylitis are associated with a higher prevalence of cardiovascular diseases (CVDs). Although traditional cardiovascular risk factors have been involved in the pathogenesis of cardiovascular diseases in rheumatic patients, these alterations do not completely explain the enhanced cardiovascular risk in this population. Obesity and its pathologic alteration of fat mass and dysfunction, due to an altered pattern of secretion of proinflammatory adipokines, could be one of the links between cardiovascular and rheumatic diseases. Indeed, the incidence of CVDs is augmented in obese individuals with rheumatic disorders. Thus, in this paper we explore in detail the relationships among adipokines, rheumatic diseases, and cardiovascular complications by giving to the reader a holistic vision and several suggestions for future perspectives and potential clinical implications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据